MIAMI, FL -- June 22, 2020 -- InvestorsHub NewsWire --
Progressive Care Inc. (RXMD)
(“Progressive Care” or the “Company”), a personalized healthcare
services and technology company, has engaged Daszkal Bolton LLP as
its new independent public accounting firm as it undertakes efforts
to transition to reporting under the Exchange Act Reporting
requirements.
Effective June 22, 2020, the Company appointed Daszkal Bolton
LLP ("Daszkal") as its independent public accounting firm for the
Company’s fiscal year ended December 31, 2020. The Company’s
decision to replace Berkowitz Pollack Brant Advisors and
Accountants, LLP (“Berkowitz”) with Daszkal was approved and
authorized by the Board of Directors of the Company upon the
recommendation of the Company’s Audit Committee.
“Our decision to choose Daszkal Bolton was based on their team’s
expertise in healthcare and SEC reporting standards,” said S.
Parikh Mars, CEO. “As we begin our transition to filing reports
with the Securities and Exchange Commission (“SEC”), we are
confident that Daszkal Bolton will be a valuable asset in these
future endeavors.”
The independent audit reports issued by Berkowitz on the
Company’s annual financial statements for the years ended December
31, 2019, 2018, 2017, 2016 did not contain an adverse opinion or
disclaimer of opinion, nor were such reports qualified or modified
as to uncertainty, audit scope or accounting principles.
During the years ended December 31, 2019, 2018, 2017 and 2016
and through June 15, 2020, there were no disagreements with
Berkowitz on any matters of accounting principles or practices,
financial statement disclosure or auditing scope or procedure,
which, if not resolved to the satisfaction of Berkowitz, would have
caused Berkowitz to make reference to the subject matter of the
disagreement in their reports on the Company’s financial statements
for such years.
“The Company is fortunate to have worked with the team at
Berkowitz Pollack Brant over the last four and half years,” said
Ms. Mars. “We knew once we began our move to full reporting status
with the SEC, we would have to part ways. Our experience with
Berkowitz has been nothing but positive and we are grateful for
their support regarding this decision.”
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Five Star RX
https://www.fivestarrx.com/
https://www.facebook.com/fivestarrx/
About Progressive Care Inc.
Progressive Care Inc. (RXMD),
through its subsidiaries, is a Florida health services organization
and provider of prescription pharmaceuticals, compounded
medications, provider of tele-pharmacy services, the sale of
anti-retroviral medications, medication therapy management (MTM),
the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words “anticipate,” “believe,” “estimate,” “upcoming,”
“plan,” “target,” “intend” and “expect” and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject to a
number of risks, uncertainties, and other factors that could cause
the Company’s actual results, performance, prospects, and
opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Investor Relations
Contact:
Armen Karapetyan,
Progressive Care Senior Advisor Business
Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations
Contact:
Carlos Rangel carlosr@pharmcorx.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Apr 2023 to Apr 2024